206 related articles for article (PubMed ID: 24676047)
1. Systematic review of N-acetylcysteine in the treatment of addictions.
Asevedo E; Mendes AC; Berk M; Brietzke E
Braz J Psychiatry; 2014; 36(2):168-75. PubMed ID: 24676047
[TBL] [Abstract][Full Text] [Related]
2. [Topiramate in substance-related and addictive disorders].
Cohen J; Dervaux A; Laqueille X
Presse Med; 2014 Sep; 43(9):892-901. PubMed ID: 25027463
[TBL] [Abstract][Full Text] [Related]
3. Potential role of N-acetylcysteine in the management of substance use disorders.
McClure EA; Gipson CD; Malcolm RJ; Kalivas PW; Gray KM
CNS Drugs; 2014 Feb; 28(2):95-106. PubMed ID: 24442756
[TBL] [Abstract][Full Text] [Related]
4. N-acetylcysteine in the treatment of craving in substance use disorders: Systematic review and meta-analysis.
Duailibi MS; Cordeiro Q; Brietzke E; Ribeiro M; LaRowe S; Berk M; Trevizol AP
Am J Addict; 2017 Oct; 26(7):660-666. PubMed ID: 28898494
[TBL] [Abstract][Full Text] [Related]
5. Use of Topiramate in the Spectrum of Addictive and Eating Disorders: A Systematic Review Comparing Treatment Schemes, Efficacy, and Safety Features.
Nourredine M; Jurek L; Angerville B; Longuet Y; de Ternay J; Derveaux A; Rolland B
CNS Drugs; 2021 Feb; 35(2):177-213. PubMed ID: 33591567
[TBL] [Abstract][Full Text] [Related]
6. N-acetyl cysteine, a glutamate-modulating agent, in the treatment of pathological gambling: a pilot study.
Grant JE; Kim SW; Odlaug BL
Biol Psychiatry; 2007 Sep; 62(6):652-7. PubMed ID: 17445781
[TBL] [Abstract][Full Text] [Related]
7. Citicoline in addictive disorders: a review of the literature.
Wignall ND; Brown ES
Am J Drug Alcohol Abuse; 2014 Jul; 40(4):262-8. PubMed ID: 24950234
[TBL] [Abstract][Full Text] [Related]
8. Clinical trials of N-acetylcysteine in psychiatry and neurology: A systematic review.
Deepmala ; Slattery J; Kumar N; Delhey L; Berk M; Dean O; Spielholz C; Frye R
Neurosci Biobehav Rev; 2015 Aug; 55():294-321. PubMed ID: 25957927
[TBL] [Abstract][Full Text] [Related]
9. Toward early estimation and treatment of addiction vulnerability: radial arm maze and N-acetyl cysteine before cocaine sensitization or nicotine self-administration in neonatal ventral hippocampal lesion rats.
Rao KN; Sentir AM; Engleman EA; Bell RL; Hulvershorn LA; Breier A; Chambers RA
Psychopharmacology (Berl); 2016 Dec; 233(23-24):3933-3945. PubMed ID: 27640177
[TBL] [Abstract][Full Text] [Related]
10. N-Acetylcysteine in depressive symptoms and functionality: a systematic review and meta-analysis.
Fernandes BS; Dean OM; Dodd S; Malhi GS; Berk M
J Clin Psychiatry; 2016 Apr; 77(4):e457-66. PubMed ID: 27137430
[TBL] [Abstract][Full Text] [Related]
11. N-acetylcysteine for treating cocaine addiction - A systematic review.
Nocito Echevarria MA; Andrade Reis T; Ruffo Capatti G; Siciliano Soares V; da Silveira DX; Fidalgo TM
Psychiatry Res; 2017 May; 251():197-203. PubMed ID: 28213190
[TBL] [Abstract][Full Text] [Related]
12. Is cocaine desire reduced by N-acetylcysteine?
LaRowe SD; Myrick H; Hedden S; Mardikian P; Saladin M; McRae A; Brady K; Kalivas PW; Malcolm R
Am J Psychiatry; 2007 Jul; 164(7):1115-7. PubMed ID: 17606664
[TBL] [Abstract][Full Text] [Related]
13. Naltrexone: A Pan-Addiction Treatment?
Aboujaoude E; Salame WO
CNS Drugs; 2016 Aug; 30(8):719-33. PubMed ID: 27401883
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological means of reducing human drug dependence: a selective and narrative review of the clinical literature.
Lin SK
Br J Clin Pharmacol; 2014 Feb; 77(2):242-52. PubMed ID: 23701272
[TBL] [Abstract][Full Text] [Related]
15. The efficacy of N-acetylcysteine in the treatment of methamphetamine dependence: a double-blind controlled, crossover study.
Mousavi SG; Sharbafchi MR; Salehi M; Peykanpour M; Karimian Sichani N; Maracy M
Arch Iran Med; 2015 Jan; 18(1):28-33. PubMed ID: 25556383
[TBL] [Abstract][Full Text] [Related]
16. Future pharmacological treatments for substance use disorders.
Forray A; Sofuoglu M
Br J Clin Pharmacol; 2014 Feb; 77(2):382-400. PubMed ID: 23039267
[TBL] [Abstract][Full Text] [Related]
17. A randomized, placebo-controlled trial of N-acetylcysteine plus imaginal desensitization for nicotine-dependent pathological gamblers.
Grant JE; Odlaug BL; Chamberlain SR; Potenza MN; Schreiber LR; Donahue CB; Kim SW
J Clin Psychiatry; 2014 Jan; 75(1):39-45. PubMed ID: 24345329
[TBL] [Abstract][Full Text] [Related]
18. N-acetyl cysteine in the treatment of cannabis use disorder: A systematic review of clinical trials.
Sharma R; Tikka SK; Bhute AR; Bastia BK
Addict Behav; 2022 Jun; 129():107283. PubMed ID: 35189496
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of oral long-term N-acetylcysteine in chronic bronchopulmonary disease: a meta-analysis of published double-blind, placebo-controlled clinical trials.
Grandjean EM; Berthet P; Ruffmann R; Leuenberger P
Clin Ther; 2000 Feb; 22(2):209-21. PubMed ID: 10743980
[TBL] [Abstract][Full Text] [Related]
20. Targeting the glutamatergic system to treat pathological gambling: current evidence and future perspectives.
Pettorruso M; De Risio L; Martinotti G; Di Nicola M; Ruggeri F; Conte G; Di Giannantonio M; Janiri L
Biomed Res Int; 2014; 2014():109786. PubMed ID: 25013755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
